ISORDIL Drug Patent Profile
When do Isordil patents expire, and when can generic versions of Isordil launch?
Isordil is a drug marketed by Wyeth Ayerst, Bausch, and Biovail. and is included in three NDAs.
The generic ingredient in ISORDIL is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isordil
A generic version of ISORDIL was approved as isosorbide dinitrate by PH HEALTH on March 12th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISORDIL?
- What are the global sales for ISORDIL?
- What is Average Wholesale Price for ISORDIL?
Summary for ISORDIL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 6 |
| Patent Applications: | 4,224 |
| Drug Prices: | Drug price information for ISORDIL |
| What excipients (inactive ingredients) are in ISORDIL? | ISORDIL excipients list |
| DailyMed Link: | ISORDIL at DailyMed |
Recent Clinical Trials for ISORDIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Brigham and Women's Hospital | Phase 4 |
| University of Cape Town | Phase 3 |
Pharmacology for ISORDIL
| Drug Class | Nitrate Vasodilator |
| Physiological Effect | Vasodilation |
US Patents and Regulatory Information for ISORDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ISORDIL | isosorbide dinitrate | CAPSULE, EXTENDED RELEASE;ORAL | 012882-002 | Jul 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-001 | Jul 29, 1988 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-002 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Biovail | ISORDIL | isosorbide dinitrate | TABLET;SUBLINGUAL | 012940-004 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Wyeth Ayerst | ISORDIL | isosorbide dinitrate | TABLET, EXTENDED RELEASE;ORAL | 012882-001 | Jul 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-007 | Jul 29, 1988 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bausch | ISORDIL | isosorbide dinitrate | TABLET;ORAL | 012093-005 | Jul 29, 1988 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
